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ABSTRACT 
Nine patients with patch tests pos itive for potassium bichromate were investigated by 
the leucocyte migration test. Specific inhibition of migration of leucocytes from patien ts 
with a llergy to chrom ium was obta ined with 3 different antigens: complexes of hexavalent 
chromium and bovine albumin, trivalent chromium and bovine a lbumin and hexavalent 
chromium and human derma l proteins. 
The highest degree of inhibition was een with hexava lent chromium-bovine albumin. 
This indicates that the spec ificity of the carrier prote in apparently is of lesser importance 
than earlier assumed. It is of in terest to notice that both hexavalent and trivalent 
chromium may be used in the antigen complexes, probably due to reduction of hexavalen t 
to triva lent chromiu m prior to binding. 
No spec ific inhibition of migration was found in patients with contact a llergy to com-
pou nds other than chromium. 
Antigen-induced inhib itio n of migration of 
macrophages (1, 2) or leucocytes (3, 4) has proved 
usefu l in clinical research and has been proposed 
as an in vitro parameter of cellular (delayed type) 
hypersensitivity (1, 2, 3). Contact a ll ergy belongs 
to the group of cellular hypersensit ivity (5, 6), and 
prelim ina ry experim ents have ind icated that the 
leucocyte migration test (LMT) may be used fo r 
detection of contact sensitivity to certa in drugs 
(7, 8). However, this method has not so far been 
used to demonstrate contact hype rsensit ivity to 
simple chemica ls. 
The present study, using the LMT in the modi -
ficat ion of Bendixen and S~borg (9, 10, 11) , is an 
attempt to demonstrate spec ific inhibition of leu-
cocytic migration from patients with a ll ergy to 
chromium. T he antigens used were extracts from 
human skin treated with hexava lent chrom ium 
and bovine albumin treated with both hexava lent 
and tr iva lent chromium. 
MATERIALS AND METHODS 
Inhibi t ion of leuc(lcyt ic m igrat ion by chromium, 
bound to bovine a lbum in a nd skin proteins, was studied 
in 9 patients with a history of a llergy to chrom ium a nd 
a positive patch test to potassiu m bichromate (0.5 per 
cent in petrolatum ) as well as in 9 contro ls. T he con-
t rols were patients attendi ng our clinic for venerea l dis-
eases. Inhibition of migration of leucocytes, using the 
same a nt igens, was a lso investi gated in 8 patients with 
allergic contact dermatitis without positive patch tests 
to chromium, but with posit ive patch tests to other 
compounds. 
Skin-chromium ant igen was prepared by binding 
chromium to ski n proteins. This was ca rri ed out by the 
methods used by Anderson (12). Human skin , obtained 
from surgica l operat ions, was soa ked in a 1 per cent so-
lution of potassiu m bichromate, stored at 4° C for a pe-
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riod of 12 hours, and then suspended in a vessel with 
running tap water. Washing was carried out for J 2 hours 
to make sure that only chromium bound to dermal pro-
teins rema ined. The tissue was homogeni zed in leuco-
cyte culture med ium (Difco TC medium 199 code 5477) 
using a motor driven glass homogen izer. The homoge-
nate was stored at 4° Cover night a nd then centrifuged 
at 1000 g for 30 minutes. T he protein concentration of 
the supernatant was determined by Lowry's method (1 3) 
a nd adjusted to 2.5 mg protein per mi. The supernatant 
was used as a nti gen in two different concentra tions, 5 11l 
or 10 11 l per culture chamber (protein concentrations of 
0.125 mg/m l or 0. 25 mg/ml) . 
An antigen consist ing of hexavalent chromium bound 
to albumin was prepared in the fo llowing manner. Two 
grams of bovine a lbumin were dissolved in 6 ml sterile 
water a nd 4 ml of l per cent. potassium bichromate was 
added. The soluti on was t hen stored at 4 o for 3 days 
and a fterwa rds dialyzed against sterile water for 3 days. 
The concentration of a lbumin after dialysi was 10 000 
mg%, and no free chrom ium cou ld be demonstrated. 
Twenty 11 l of t he solu t ion, corresponding to 2000 mg% 
a lbumin, were used as ant igen in the culture chambers. 
Another a ntigen was made from bovine a lbumin 
treated with tr iva lent chrom iu m. Five hundred mg of 
bovine a lbumin were dissolved in a solution of 10 ml 
conta ining 50 rng chromium sulphate (triva lent chrom-
ium). Afte r 3 days of incubation at 4° C the solution 
was dia lyzed aga inst sterile water and the a mount of 
a lbumin was approx im ately 2500 mg%. Fifteen 11l of the 
solution was used as a ntigen per cultu re chamber. The 
concentration of a lbum in in the culture chambers was 
approximately 375 mg%. 
The solut ions of antigens were adjusted to pH 7.3 
before use. 
The presence of chrom ium in skin homogenates as 
well as in albumin solutions, after dialys is, was dem on-
strated by gas chromatography (14). 
Hepari ni zed blood was obtained from patients as well 
as from controls a nd a llowed to sediment sponta neously 
for 1 hour at 37° . The white blood cells were removed 
and washed 3 t im es in Hanks balanced salt solu tion. 
T he cell suspensions then were t ransferrEd to capillary 
tubes and the leucocytes allowed to migrate for 24 hours 
in the culture chambers (3). Identical sets of cultu re 
chambers were set up for controls a nd patients, two 
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control cul tures within each set wi thout ant igen, fill ed 
with TC medium 199, and dupli cate cultures for each 
antigen. After 20 hours the migration areas of the leuco-
cytes arou nd the opening of the ca pi llary tubes were 
measured in a projection microscope. The ave rage mi -
gra ti on area for two identi ca l cultures, conta ining an-
t ige n (Mx) and TC medium alone (Mo) from the sa me 
blood sa mple determines the mi grat ion in dex (Mi): 
Mx 
Mi = -
Mo 
A va lue of less than 1.0 indi ca tes inhi bition of migra-
t ion due to the added ant igen. 
RESULTS 
F igu re 1 shows inhibi t ion of migration of leuco-
cytes from subjects wi t h a ll ergy to chromium 
com pared wi t h con t rols. S pecific inhibition of 
mi grat ion of leucocytes from pe rsons with a lle rgy 
to chromium was ob tained by us ing human skin 
as well as a lbumin , both t reated wi t h hexava lent 
chromiu m, as a n t ige ns . In a ll cases t he migra tion 
indices from subjects wi t h contac t d erma ti t is to 
chromium we re s ignifi cantl y lower tha n those 
obta ined fro m con t ro ls (P < 0.02 when us ing 5 J.d 
s kin -chrom ium complex as a nt igen in the cul ture 
cha mbers a nd P < 0.05 when us ing 10 ~1). Appli -
ca tion of hexava len t chromium , bound to bov ine 
a lbumin, resul ted in hi ghly s ignifica nt lower mi -
gra tion indices a mong chromium a ll ergic subject~ 
compared wi t h co nt rols (P < 0.001). In the Fi gur~ 
the normal ra nge of mi gration indices for co ntrol% 
is indi cated as the mea n va lue 2 x SD. All mi, 
grat ion indices from patients a ll ergic to chrom iun\ 
fa ll beyo nd the norma l range for th e con t rols. Ta, 
ble I sh ows a compa ri son between cont rols wi th, 
ou t contact a ll e rgy a nd con t rols with pos i tiv~ 
patch tests to othe r compounds tha n chromiu n.1 
In thi s case hexava len t chrom ium, bound to bov i n~ 
a lbumin, 20 ~d pe r cha mber, was used as a nt igen 
No s ignifi ca n t diffe rence between mi gration in: 
dices in t he two groups of control s could be d e111, 
onstrate d . In Tabl e II mi gration indi ces from 5 pa, 
ti en ts with posit ive patch tests to chromium an~ 
5 m atched con t rols with contac t a ll ergy to othet 
compounds t ha n chromium a re de monstrated, 
Triva len t chromium bound to bovin e albu mit1 
was used as antigen . The diffe rence between mi. 
gra ti o n indi ces from patien ts a ll ergic to 
chromium and cont rols a ll ergic to other chemical 
is s ignifi can t (P < 0.01) . 
DISCUSSION 
Our results show tha t d elayed hy persensitivity 
to potassium bichromate may be demonstrated in 
vitro by LMT. The highes t degree of s pecifi c inhi-
bitio n of leucocytes was obta ined by u sing 
chromium bound to bovine a lbumin . Both hexa-
va len t chromium a nd t riva len t chromium bound to 
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F'JGU HE 1. Leucocyte mi gration indices in pati ents a ll ergic to chromiu m (x ) and normal human subjects (0). 
Chrom ium /s kin extract (5 1-'1 and 10 1-'1 per chamber) a nd hexavalent chrom ium/a lbumin (20 ~tl per chamber} were 
used as ant ige ns. Fo r chromium/albumin the normal range for the contro ls is indicated as the mea n va lue of th~ , 
indices ± 2 x SD. 
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TABLE I Co mpa rison of' two control groups. One consisting of' subjects wi thout contact allergy, the other of pa-
tients with contact allergy to other compounds tha n chrom ium. Hexava lent chromium/a lbumin was used as an-
tigen. 
Ht.:X.::tva l cn t c hr~orn iurn/u l burn in 
Con t r"'O l ::. wi t ~ ' out Con t r~o t s w i t ~ posi t ive pa tc h 
l l.-'5 1 to o th e r a g "' !''It S th .:tn c hro mium 
M igr•u t iun tnclf'' M igr u ti on ind c>. 
0 . 80 0, 8 6 { l <.m o l in) 
0 . 95 0 . 8 4 ( r ub b e r) 
0. 85 I. 0 1 (n <•om ycin) 
0 . 83 0 . 8 6 {p-ph en y l encdi arnin) 
0 . 93 I. I 3 (ni cke l) 
0 . ':}ll 0 , 89 ( Pcr· ub a l sam) 
I . 00 
0 . 8Lr I. 0 9 ( r ubbe•· ) 
0 . 93 0. 76 (Per ub a l som ) 
M cun 0 , 55 Mean 93 . 00 
SEM -.:._ 0 . 058 1 SEM ~ 0 . Qtr58 
P 0 , I 
TABLE Il Leucocyte migration indi ces in patients with contact nllergy to chromium and pa tients with contact al-
lergy to other chemi cals than chromium. Th ese agents are indica ted in brackets . Triva lent chromium /albu min was 
used as a nt tge n. 
T r~ i vn l cn t c h r .. omium/ u lbumin 
Pu t icnt s wi th pos i t ive pat c h 
1 cs 1 to c hr•orn i um 
Migr·a t ion ind ,.. 
0. 78 
0,87 
0,68 
0. 93 
0.99 
M e an 0 . 85 
S EM :!: 0.05 
p o. 0 1 
albumin resulted in usable a nt igens. Skin/ cluo-
miu m extracts were used to achieve the specific 
protein-chromium complex. The importa nce of 
t he carrier protein to the spec ifi c inhibi t ion of 
t he machrophage migration previously has been 
C o n t r o l s wi th pos iti ve pa t h 
tes t to o th er ugcnt s tha n c h romium 
Migra t ion index 
0. 94 (p-pl"'l cn y te n e di a m in) 
I. 33 (ni c k e l) 
1, 08 (Pcruba l s am) 
I. 26 ( rubber) 
I. 13 ( P r· uba l s am ) 
M ea n I . 14 
SEM:!: 0. 06 
demonstrated (15, 16). In our case however, dermal 
proteins other than the chromium complex may 
have resulted in some non-specific inhibition. 
The marked inhibition found in the LMT, when 
chromium bound to albumin was used as antigen, 
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seems to indicate that the specificity of the car-
rier protein is of smaller s ignificance than earli er 
assumed (1, 15). This is in accordance with the 
results of Cohen (17, 18), who found that patients 
suffering from contact dermatitis due to chro-
mium showed positive intradermal reaction to 
chromium chloride and to complexes of chromium 
chloride and human serum albumin or heparin . 
Both trivalent and hexavalent chromium com-
plexes resulted in usable antigens. Probably most 
hexavalent chromium undergoes reduction to tri-
valent chromium prior to binding to protein (19). 
However, in our case, the two experimenta l con-
ditions are not comparable. Different amounts of 
albumin have been used in the two conditions. 
Also the toxicity of possible remaining amounts 
of non-protein bound chromium is far greater for 
hexavalent than for trivalent chromium. Our data 
show that contact allergy to other compounds 
than chromium does not seem to influence the 
test. 
The results of our study suggest that LMT may 
find its place in dermatology. The advantages of 
an in vitro test are obvious. Risks of sensitization 
due to the procedure do not exist, and testing can 
be carried out at all clinical stages. 
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